Molecular Cardiovascular Research Program, Department of Physiology, University of Arizona Tucson, AZ, USA.
Front Physiol. 2013 Aug 27;4:205. doi: 10.3389/fphys.2013.00205. eCollection 2013.
Although familial hypertrophic cardiomyopathy (FHC) is characterized as cardiac disease in the absence of overt stressors, disease penetrance, and pathological progression largely depend on modifying factors. Accordingly, pressure overload by transverse aortic constriction (TAC) was induced in 2-month-old, male mice with and without a FHC (R403Q) mutation in α-myosin heavy chain. A significantly greater number of FHC mice (n = 8) than wild-type (WT) mice (n = 5) died during the 9-week study period. TAC induced a significant increase in cardiac mass whether measured at 2 or 9 weeks post-TAC in both WT and FHC mice, albeit to a different extent. However, the temporal and morphological trajectory of ventricular remodeling was impacted by the FHC transgene. Both WT and FHC hearts responded to TAC with an early (2 weeks post-TAC) and significant augmentation of the relative wall thickness (RWT) indicative of concentric hypertrophy. By 9 weeks post-TAC, RWT decreased in WT hearts (eccentric hypertrophy) but remained elevated in FHC hearts. WT hearts following TAC demonstrated enhanced cardiac function as measured by the end-systolic pressure-volume relationship, pre-load recruitable stroke work (PRSW), and myocardial relaxation indicative of compensatory hypertrophy. Similarly, TAC induced differential histological and cellular remodeling; TAC reduced expression of the sarcoplasmic reticulum Ca(2+)-ATPase (2a) (SERCA2a; 2 and 9 weeks) and phospholamban (PLN; 2 weeks) but increased PLN phosphorylation (2 weeks) and β-myosin heavy chain (β-MyHC; 9 weeks) in WT hearts. FHC-TAC hearts showed increased β-MyHC (2 and 9 weeks) and a late (9 weeks) decrease in PLN expression concomitant with a significant increase in PLN phosphorylation. We conclude that FHC hearts respond to TAC induced pressure overload with increased premature death, severe concentric hypertrophy, and a differential ability to undergo morphological, functional, or cellular remodeling compared to WT hearts.
虽然家族性肥厚型心肌病 (FHC) 表现为无明显应激因素的心脏疾病,但疾病的外显率和病理进展在很大程度上取决于修饰因子。因此,在 2 个月大的雄性小鼠中,通过横主动脉缩窄 (TAC) 诱导 FHC(R403Q)突变的α肌球蛋白重链和无 FHC 突变的小鼠。在 9 周的研究期间,FHC 小鼠(n=8)的死亡人数明显多于野生型(WT)小鼠(n=5)。TAC 诱导的心脏质量增加在 WT 和 FHC 小鼠中无论是在 TAC 后 2 周还是 9 周均显著增加,尽管程度不同。然而,FHC 转基因影响了心室重构的时间和形态轨迹。WT 和 FHC 心脏均对 TAC 产生反应,相对壁厚度(RWT)早期(TAC 后 2 周)和显著增加,提示为向心性肥厚。TAC 后 9 周,WT 心脏的 RWT 降低(离心性肥厚),但 FHC 心脏的 RWT 仍升高。TAC 后 WT 心脏的收缩末期压力-容积关系、预负荷可获得的收缩功(PRSW)和心肌松弛性增强,表明存在代偿性肥厚。同样,TAC 诱导了不同的组织学和细胞重构;TAC 降低了肌浆网 Ca(2+)-ATP 酶(2a)(SERCA2a;2 和 9 周)和磷蛋白(PLN;2 周)的表达,但增加了 PLN 磷酸化(2 周)和β肌球蛋白重链(β-MyHC;9 周)在 WT 心脏中。FHC-TAC 心脏显示出增加的β-MyHC(2 和 9 周)和 PLN 表达的晚期(9 周)下降,同时 PLN 磷酸化显著增加。我们得出结论,与 WT 心脏相比,FHC 心脏对 TAC 诱导的压力超负荷的反应是过早死亡增加、严重的向心性肥厚以及形态、功能或细胞重构的能力差异。